2-Tetralin-1-yl-4,5-dihydro-1H-imidazole hydrochloride
Synonym(s):4,5-Dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1H-imidazole monohydrochloride;Tetrahydrozoline hydrochloride;Tetryzoline hydrochloride
- CAS NO.:522-48-5
- Empirical Formula: C13H17ClN2
- Molecular Weight: 236.74
- MDL number: MFCD00058029
- EINECS: 208-329-3
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-19 23:02:33
What is 2-Tetralin-1-yl-4,5-dihydro-1H-imidazole hydrochloride?
Chemical properties
Off-White Solid
Originator
Tyzine,Pfizer,US,1954
The Uses of 2-Tetralin-1-yl-4,5-dihydro-1H-imidazole hydrochloride
2-Tetralin-1-yl-4,5-dihydro-1H-imidazole hydrochloride is an alpha agonist, causing constriction of conjunctival blood vessels,it is used in over-the-counter eye drops, this compound relieves the redness left by ocular irritants.
The Uses of 2-Tetralin-1-yl-4,5-dihydro-1H-imidazole hydrochloride
adrenergic agonist, nasal decongestant
The Uses of 2-Tetralin-1-yl-4,5-dihydro-1H-imidazole hydrochloride
An alpha agonist, causing constriction of conjunctival blood vessels. Used in over-the-counter eye drops, this compound relieves the redness left by ocular irritants.
What are the applications of Application
Tetrahydrozoline hydrochloride is an α activator in the constriction of conjuctival blood vessels
Definition
ChEBI: Tetrahydrozoline hydrochloride is the hydrochloride salt of tetryzoline. It is used as a nasal decongestant. It has a role as a sympathomimetic agent, a vasoconstrictor agent and a nasal decongestant. It contains a tetryzoline(1+).
Manufacturing Process
A mixture of 540 grams (9.0 mols) of ethylenediamine, 270 grams (1.53
mols) of 1,2,3,4tetrahydro-α-naphthoic acid, and 360 ml (4.32 mols) of
concentrated hydrochloric acid was introduced into a two-liter, three-necked
flask fitted with a thermometer, stirrer, and distillation takeoff. The mixture
was distilled under a pressure of about 20 mm of mercury absolute until the
temperature rose to 210°C. Thereafter, heating was continued under
atmospheric pressure and when the temperature reached about 260°C, an
exothermic reaction was initiated. The heat was then adjusted to maintain a
reaction temperature of 275° to 280°C for 45 minutes and the mixture
thereafter cooled to room temperature.
900 ml of 4 N hydrochloric acid was added and the aqueous layer stirred with
warming until a clear, brown solution resulted. This brown solution was made
strongly alkaline with sodium hydroxide. The oil that separated solidified and
was collected on a filter leaving filtrate A. The solid was dissolved in 370 ml of
alcohol with warming, and the solution was treated with 130 ml of
concentrated hydrochloric acid with stirring and cooling. This acidified mixture
was diluted with 300 ml of ether and chilled. The solid salt was collected and
dried and the filtrate concentrated to approximately 300 ml, diluted with 300
ml of ether and the salt which separated collected and dried.
Filtrate A was extracted with ether, dried, acidified with alcoholic hydrogen
chloride, and the salt which separated was collected and dried. There was
thus obtained, when all the salt had been combined, 250 grams (69.3% of the
theoretical yield) of 2-(1,2,3,4-tetrahydro-1-naphthyl)imidazoline
hydrochloride, melting at 256° to 257°C.
brand name
Tetryzo- line is INN and BAN; Tetryzoline Hydrochloride is JAN; Tetrahydrozoline Nitrate is JAN.
Therapeutic Function
Nasal decongestant, Pharmaceutic aid
Properties of 2-Tetralin-1-yl-4,5-dihydro-1H-imidazole hydrochloride
Melting point: | 248-251°C |
storage temp. | Inert atmosphere,Room Temperature |
solubility | H2O: freely soluble |
form | neat |
form | Solid |
color | White to Off-White |
CAS DataBase Reference | 522-48-5(CAS DataBase Reference) |
EPA Substance Registry System | 1H-Imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, monohydrochloride (522-48-5) |
Safety information for 2-Tetralin-1-yl-4,5-dihydro-1H-imidazole hydrochloride
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H302:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P270:Do not eat, drink or smoke when using this product. P301+P312:IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. P302+P352:IF ON SKIN: wash with plenty of soap and water. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for 2-Tetralin-1-yl-4,5-dihydro-1H-imidazole hydrochloride
InChIKey | BJORNXNYWNIWEY-UHFFFAOYSA-N |
New Products
4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium THOMAIND PAPER PH 2.0 TO 4.5 1 BOX BUFFER CAPSULE PH 9.2 - 10 CAP SODIUM CHLORIDE 0.1N CVS ALLOXAN MONOHYDRATE 98% PLATINUM 0.5% ON 3 MM ALUMINA PELLETS (TYPE 73) LITHIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
Tetrahydrozoline HCl 95% CAS 522-48-5View Details
522-48-5 -
Tetrahydrozoline Hydrochloride CAS 522-48-5View Details
522-48-5 -
Tetrahydrozoline HCl 98% (HPLC) CAS 522-48-5View Details
522-48-5 -
Tetrahydrozoline hydrochloride CAS 522-48-5View Details
522-48-5 -
Tetrahydrozoline hydrochloride CAS 522-48-5View Details
522-48-5 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Lithium ClavulanateView Details
61177-44-4